LBA56 MEDI5752 or pembrolizumab (P) plus carboplatin/pemetrexed (CP) in treatment-naïve (1L) non-small cell lung cancer (NSCLC): A phase Ib/II trial

M-J. Ahn, S-W. Kim, E. Carcereny Costa, Laura Rodríguez, Jorge Oliveira, M.A. Insa Molla, Margarita Majem, Luís Costa, Wu‐Chou Su, K.H. Lee, James Chih‐Hsin Yang, David R. Spigel, E.K. Cho, M. D’Arcangelo, M.R. García Campelo, Angelo Delmonte, P. Mitchell, Ikbel Achour, Deepa S. Subramaniam, Enriqueta Felip